HOME >> BIOLOGY >> NEWS
Diet a major factor in breast cancer time for government action

Hamburg, Germany: The rapid increase in the knowledge of breast cancer determinants and the continuing increase in incidence of breast cancer means that it is time to move from knowledge to action, a scientist said today (Friday 19 March) at the 4th European Breast Cancer Conference. Dr. Franco Berrino, head of preventive and predictive medicine at the Instituto Nazionale Tumori, Milan, Italy, said that high levels of sex hormones and insulin-like growth factors were associated with cancer risk, and that the typical western diet increased their biological effect.

"Breast cancer risk can be reduced by avoiding hormone replacement therapy, increasing physical activity, not being overweight, and eating a more healthy diet", said Dr. Berrino. "The problem with the diet of most people in the West is that it tends to include processed foods high in sugars and fats, too much red meat and dairy products, and not enough unrefined grains and vegetable products. This diet reduces the body's sensitivity to insulin, and this in turn stimulates the production of sex hormones and other growth factors, which are directly linked to breast cancer risk."

Eating more of the latter and less of the former food groups would not only reduce obesity, but would reduce the risk of several cancers, as well as cardiovascular and other chronic diseases, he said.

Dr. Berrino is currently looking at the effect of diet and hormonal risk factors in women carrying a mutated BRCA1 and BRCA 2 gene, the most common mutation found in breast cancer. These women have a very high lifetime risk of developing breast cancer, and most of them develop the disease in their 30s or 40s. However, he said, it is not clear why some mutation carriers develop the disease and others do not, nor why some develop it early and some much later in life. "Our hypothesis is that the incidence of breast cancer among mutation carriers depends on environmental factors, of which diet will be a ma
'"/>

Contact: Mary Rice
mary.rice@blueprintpartners.be
49-403-569-3625
Federation of European Cancer Societies
18-Mar-2004


Page: 1 2

Related biology news :

1. Brown ecologist garners major National Science Foundation grant
2. Genetic mutation found that is major contributor to type 1 diabetes
3. Researchers report major advance in gene therapy technique
4. K-State business researchers to help with major study on food supply veterinary medicine
5. NPS Pharma and VIMAC Ventures locate at MaRS, a major new research and enterprise center in Toronto
6. Kinase backgrounder: Iressa discovery part of major kinase project at Dana-Farber
7. Inflammation, hypertension are focus of major new MCG research program
8. Gene plays major role in formation of stem cells and cancer
9. Researchers make major gain in understanding how prions jump species
10. Scientists crack genome sequence of a major parasitic pathogen
11. More evidence of major global extinctions

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... , ... July 30, 2020 , ... ... digital therapeutics product portfolio with a near term focus on Type 2 diabetes ... pharma commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While ... global economic downturn will only increase price pressures overall for the industry. The era ... from every product launch is critical. However, history shows that only a third of ...
(Date:7/4/2020)... , ... July 03, 2020 , ... ... to earn outstanding recognition and multiple awards for not only the products and ... portfolio, SoME® Skincare and Vivace® Microneedle RF. All the brands built by ABM ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... 2020 , ... R3 International is now offering stem cell therapy for Alzheimers ... Depending on the patient's condition, treatment may be offered IV, intrathecal or with a ... of Alzheimers dementia, and the incidence continues to increase as individuals live longer. There ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... insights, today announced that the launch of a new clinical diagnostics ... about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that ...
(Date:6/28/2020)... Md. (PRWEB) , ... June 26, 2020 , ... ... trade association representing security solutions providers, today announced its strong opposition to the ... The bill would impose a blanket ban on most federal use of nearly ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen ... will be presented June 22-24 during the American Association for Cancer Research Virtual ... other profiles the potent, consistent single agent activity in KEAP1 mutant tumor models ...
Breaking Biology Technology:
Cached News: